Take part in the Hamilton-based OCEANIC-AF study. Led by Dr. Rick Tytus, we're exploring asundexian's role in stroke prevention. Your health, our focus.
Research Ethics Board approved. No pressure, just information.
Trust in experience: Dr. Rick Tytus, a renowned and award-winning physician
Complete an initial questionnaire to determine whether you meet the basic criteria for participation. This involves questions related to your atrial fibrillation condition and general health status.
Attend 1 or 2 visits to our Hamilton clinic where Dr. Rick Tytus and the team will conduct an ECG, physical examination, and possibly blood tests for genetic testing to confirm your eligibility.
Once approved, you’ll be enrolled in the study. You will be provided with study tablets and instructions. A computer program will randomly assign you either the investigational drug or the comparator, in a double-blind manner.
Scheduled visits will occur approximately every 3 months, some of which may be via telephone. You’ll be asked to report any new symptoms, medication changes, or side effects. Blood tests and questionnaires may also be conducted.
© Copyright 2023, All Rights Reserved by Hamilton Medical Research Group Inc.